Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6427
-0.0073 (-1.12%)
Jan 15, 2026, 4:00 PM EST - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $77.31 million as of January 15, 2026. Its market cap has decreased by -16.68% in one year.
Market Cap
77.31M
Enterprise Value
43.85M
1-Year Change
-16.68%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $77.31M, a decrease of -68.27%. That is a compound annual growth rate of -15.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 78.19M | 21.79% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.48B |
| Johnson & Johnson | 512.77B |
| AbbVie | 386.61B |
| UnitedHealth Group | 305.26B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 268.80B |
| Novo Nordisk | 263.26B |